These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23349487)

  • 1. Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.
    Kimple ME; Keller MP; Rabaglia MR; Pasker RL; Neuman JC; Truchan NA; Brar HK; Attie AD
    Diabetes; 2013 Jun; 62(6):1904-12. PubMed ID: 23349487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E
    Neuman JC; Schaid MD; Brill AL; Fenske RJ; Kibbe CR; Fontaine DA; Sdao SM; Brar HK; Connors KM; Wienkes HN; Eliceiri KW; Merrins MJ; Davis DB; Kimple ME
    Diabetes; 2017 Jun; 66(6):1572-1585. PubMed ID: 28193789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.
    Wisinski JA; Reuter A; Peter DC; Schaid MD; Fenske RJ; Kimple ME
    Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E479-E489. PubMed ID: 34229444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.
    Sandhu HK; Neuman JC; Schaid MD; Davis SE; Connors KM; Challa R; Guthery E; Fenske RJ; Patibandla C; Breyer RM; Kimple ME
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00736. PubMed ID: 33694300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prostaglandin E
    Neuman JC; Reuter A; Carbajal KA; Schaid MD; Kelly G; Connors K; Kaiser C; Krause J; Hurley LD; Olvera A; Davis DB; Wisinski JA; Gannon M; Kimple ME
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E567-E576. PubMed ID: 38477664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EP3 signaling is decoupled from the regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance.
    Schaid MD; Harrington JM; Kelly GM; Sdao SM; Merrins MJ; Kimple ME
    Islets; 2023 Dec; 15(1):2223327. PubMed ID: 37415404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism.
    Shridas P; Zahoor L; Forrest KJ; Layne JD; Webb NR
    J Biol Chem; 2014 Oct; 289(40):27410-7. PubMed ID: 25122761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
    Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological blockade of the EP3 prostaglandin E
    Bosma KJ; Andrei SR; Katz LS; Smith AA; Dunn JC; Ricciardi VF; Ramirez MA; Baumel-Alterzon S; Pace WA; Carroll DT; Overway EM; Wolf EM; Kimple ME; Sheng Q; Scott DK; Breyer RM; Gannon M
    Mol Metab; 2021 Dec; 54():101347. PubMed ID: 34626853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function.
    Tran PO; Gleason CE; Robertson RP
    Diabetes; 2002 Jun; 51(6):1772-8. PubMed ID: 12031964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Cox-2 and prostaglandin E
    Amior L; Srivastava R; Nano R; Bertuzzi F; Melloul D
    FASEB J; 2019 Apr; 33(4):4975-4986. PubMed ID: 30629897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.
    Chan PC; Hsiao FC; Chang HM; Wabitsch M; Hsieh PS
    FASEB J; 2016 Jun; 30(6):2282-97. PubMed ID: 26932930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.
    Sloop KW; Willard FS; Brenner MB; Ficorilli J; Valasek K; Showalter AD; Farb TB; Cao JX; Cox AL; Michael MD; Gutierrez Sanfeliciano SM; Tebbe MJ; Coghlan MJ
    Diabetes; 2010 Dec; 59(12):3099-107. PubMed ID: 20823098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual role of group V secretory phospholipase A
    Shridas P; Noffsinger VP; Trumbauer AC; Webb NR
    Endocrine; 2017 Oct; 58(1):47-58. PubMed ID: 28825176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.